Publications by authors named "Niklaus Meier"

Claim this Profile
S
Systematic review of cost-effectiveness modelling studies for haemophilia.
Niklaus Meier, Daniel Ammann, Mark Pletscher, Jano Probst, Matthias Schwenkglenks

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations.
Niklaus Meier, Ana Cecilia Quiroga Gutierrez, Mark Pletscher, Matthias Schwenkglenks

Pharmacoeconomics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Joachim Marti, Niklaus Meier

Rev Med Suisse· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to comment by Arber C, et al. on: Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland.
Maria Trottmann, Eva Blozik, Marcel Hilbig, Mark Pletscher, Niklaus Meier

Swiss Med Wkly· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany.
Niklaus Meier, Hendrik Fuchs, Katya Galactionova, Cedric Hermans, Mark Pletscher

Pharmacoecon Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.
Michaela Carla Barbier, Alicia Fengler, Esther Pardo, Arjun Bhadhuri, Niklaus Meier

Pharmacoeconomics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Maria Trottmann, Eva Blozik, Marcel Hilbig, Daniel LoVerdi, Marcello Pedruzzi, Niklaus Meier

Swiss Med Wkly· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
Serge Pinto, Adelheid Nebel, Jörn Rau, Robert Espesser, Pauline Maillochon, Niklaus Meier

Mov Disord· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
Andreas R Gantenbein, Reto Agosti, Christian P Kamm, Gunther Landmann, Niklaus Meier

J Headache Pain· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
Andreas R Gantenbein, Reto Agosti, Christian P Kamm, Gunther Landmann, Niklaus Meier

J Headache Pain· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Reasoning: A Dizzy Architect.
Adrian Scutelnic, Aikaterini Galimanis, Michael Horn, Lidia Sabater, Niklaus Meier

Neurology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment.
Jörg Wissel, Klemens Fheodoroff, Maurits Hoonhorst, Martina Müngersdorf, Philippe Gallien, Niklaus Meier

Front Neurol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation.
Brian Lau, Niklaus Meier, Giulia Serra, Virginie Czernecki, Michael Schuepbach

Neurology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid outflow resistance as a diagnostic marker of spontaneous cerebrospinal fluid leakage.
Jürgen Beck, Christian Fung, Christian T Ulrich, Michael Fiechter, Jens Fichtner, Niklaus Meier

J Neurosurg Spine· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
Andreas Hartmann, Julia Müllner, Niklaus Meier, Helke Hesekamp, Priscilla van Meerbeeck

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diskogenic microspurs as a major cause of intractable spontaneous intracranial hypotension.
Jürgen Beck, Christian T Ulrich, Christian Fung, Jens Fichtner, Kathleen Seidel, Niklaus Meier

Neurology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
Andreas Hartmann, Julia Muellner, Niklaus Meier, Helke Hesekamp, Priscilla van Meerbeeck

PLoS One· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keeping an Eye on This Headache.
Matthias Hoheisel, Matthias Sturzenegger, Niklaus Meier

JAMA Neurol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
Julia Muellner, Iman Gharrad, Marie-Odile Habert, Aurélie Kas, Jean-Baptiste Martini, Niklaus Meier

Parkinsonism Relat Disord· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.
Marcel Arnold, Selina Mattle, Aekaterini Galimanis, Liliane Kappeler, Urs Fischer, Niklaus Meier

Int J Stroke· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring cerebral oxygenation during balloon occlusion with multichannel NIRS.
Christian Rummel, Christoph Zubler, Gerhard Schroth, Jan Gralla, Kety Hsieh, Niklaus Meier

J Cereb Blood Flow Metab· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical polyradiculopathy caused by vertebral artery dissection.
Franca Wagner, Marie-Luise Mono, Harold Köndgen, Roland Wiest, Niklaus Meier

Lancet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular therapy of 623 patients with anterior circulation stroke.
Aekaterini Galimanis, Simon Jung, Marie-Luise Mono, Urs Fischer, Oliver Findling, Niklaus Meier

Stroke· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of thrombolysis on stroke outcome at 12 months in a population: the Bern stroke project.
Urs Fischer, Marie-Luise Mono, Marcel Zwahlen, Krassen Nedeltchev, Marcel Arnold, Niklaus Meier

Stroke· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.
Gian Marco De Marchis, Simon Jung, Giuseppe Colucci, Niklaus Meier, Urs Fischer

Stroke· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis